Managing debilitating menopausal symptoms

Area of Science:

• Reproductive Endocrinology
• Women's Health
• Menopause Management

Background:

• Menopausal symptoms exhibit significant variability in severity and duration.
• Approximately 80% of women experience symptoms, averaging four years, with 10% enduring them for up to 12 years.
• Symptom onset timing influences duration, with pre-menopausal onset linked to longer symptom experience.

Purpose of the Study:

• To evaluate the duration and characteristics of menopausal symptoms.
• To provide guidance on assessing menopausal status and hormone replacement therapy (HRT) indications.
• To outline risk assessment strategies for HRT use.

Main Methods:

• Analysis of symptom duration based on onset relative to menopause.
• Review of diagnostic criteria for menopausal status, including hormone level testing.
• Guidelines for HRT prescription, risk stratification, and management of comorbidities.

Main Results:

• Women experiencing vasomotor symptoms before menopause had a median duration of 11.8 years, versus 3.4 years for those starting after menopause.
• Menopausal status evaluation relies on history and symptoms; FSH testing is reserved for specific age groups and suspected early menopause.
• Short-term HRT benefits generally outweigh risks for symptomatic women under 60, with no proven cardiovascular or dementia protection.

Conclusions:

• Menopausal symptom duration is variable and influenced by onset timing.
• HRT is beneficial for symptomatic women under 60, but requires careful cardiovascular risk assessment.
• Individualized management is crucial, considering comorbidities like cardiovascular disease, venous thromboembolism risk, and breast cancer risk.